Skip to content
★ Sign in to follow
BW

Brian Wiley

Executive
Lumos Pharma, Inc.
Total declarations
29
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (13 ops.)
€3.2M

Latest filing published 04 Jan 2018 for Lumos Pharma, INC., €8,723.

Insider track record

Disclosed buys
0
Disclosed sells
13
Signal history

Brian Wiley: trading record in brief

Brian Wiley discloses dealings in Lumos Pharma, Inc. to SEC (Form 4). We count 29 filings; the first trade dates from 2 January 2014 and the latest from 4 January 2018.

No open-market purchase appears, only 13 sales worth €3.2M. Outside the open market, there are 8 share grants and 8 option exercises.

The newest entry dates from 4 January 2018: a share grant of €8,723, in Lumos Pharma, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Brian Wiley

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations29 total
  • ◆
    Chief Commercial OfficerExecutivesLumos Pharma, Inc.
    10,477 USD12SEC
    1,237 shares@ US$8.4711.8% of flowCommon StockSEC:0001126234-18-000009:0
  • ◆
    Chief Commercial OfficerExecutivesLumos Pharma, Inc.
    6,066 USD12SEC
    603 shares@ US$10.066.8% of flowCommon StockSEC:0001126234-18-000009:1
  • ◆
    Chief Commercial OfficerExecutivesLumos Pharma, Inc.
    12,716 USD13SEC
    1,237 shares@ US$10.2816.4% of flowCommon StockSEC:0001126234-17-000011:0
  • ◆
    Chief Commercial OfficerExecutivesLumos Pharma, Inc.
    6,657 USD12SEC
    603 shares@ US$11.048.6% of flowCommon StockSEC:0001126234-17-000011:1
  • ◆
    VP of Business DevelopmentExecutivesLumos Pharma, Inc.
    0SEC
    6,382 sharesCommon StockSEC:0001126234-16-000209:0
  • ▼
    VP of Business DevelopmentExecutivesLumos Pharma, Inc.
    10,107 USD31SEC
    295 shares@ US$34.2622.3% of flowCommon StockSEC:0001126234-16-000209:1
  • ▼
    VP of Business DevelopmentExecutivesLumos Pharma, Inc.
    35,200 USD37SEC
    1,000 shares@ US$35.2077.7% of flowCommon StockSEC:0001126234-16-000209:2
  • ◇
    VP of Business DevelopmentExecutivesLumos Pharma, Inc.
    235,800 USD0SEC
    20,000 shares@ US$11.79Common StockSEC:0001126234-15-000042:0
  • ▼
    VP of Business DevelopmentExecutivesLumos Pharma, Inc.
    165,113 USD0SEC
    3,750 shares@ US$44.03Common StockSEC:0001126234-15-000042:1
  • ▼
    VP of Business DevelopmentExecutivesLumos Pharma, Inc.
    675,750 USD0SEC
    15,000 shares@ US$45.05Common StockSEC:0001126234-15-000042:2
  • ▼
    VP of Business DevelopmentExecutivesLumos Pharma, Inc.
    57,800 USD0SEC
    1,250 shares@ US$46.24Common StockSEC:0001126234-15-000042:3
  • ◇
    VP of Business DevelopmentExecutivesLumos Pharma, Inc.
    117,900 USD0SEC
    10,000 shares@ US$11.79Common StockSEC:0001126234-15-000034:0
  • ▼
    VP of Business DevelopmentExecutivesLumos Pharma, Inc.
    400,700 USD0SEC
    10,000 shares@ US$40.07Common StockSEC:0001126234-15-000034:1
  • ◆
    VP of Business DevelopmentExecutivesLumos Pharma, Inc.
    23,571 USD0SEC
    540 shares@ US$43.65Common StockSEC:0001126234-15-000010:0
  • ◆
    VP of Business DevelopmentExecutivesLumos Pharma, Inc.
    0SEC
    7,400 shares0Common StockSEC:0001126234-15-000010:1
  • ◇
    VP of Business DevelopmentExecutivesLumos Pharma, Inc.
    235,800 USD0SEC
    20,000 shares@ US$11.79Common StockSEC:0001126234-15-000010:2
  • ▼
    VP of Business DevelopmentExecutivesLumos Pharma, Inc.
    396,800 USD0SEC
    10,000 shares@ US$39.68Common StockSEC:0001126234-15-000010:3
  • ▼
    VP of Business DevelopmentExecutivesLumos Pharma, Inc.
    409,800 USD0SEC
    10,000 shares@ US$40.98Common StockSEC:0001126234-15-000010:4
  • ◇
    VP of Business DevelopmentExecutivesLumos Pharma, Inc.
    235,800 USD0SEC
    20,000 shares@ US$11.79Common StockSEC:0001126234-14-000056:0
  • ▼
    VP of Business DevelopmentExecutivesLumos Pharma, Inc.
    728,200 USD0SEC
    20,000 shares@ US$36.41Common StockSEC:0001126234-14-000056:1
  • ◇
    VP of Business DevelopmentExecutivesLumos Pharma, Inc.
    117,900 USD0SEC
    10,000 shares@ US$11.79Common StockSEC:0001126234-14-000051:0
  • ▼
    VP of Business DevelopmentExecutivesLumos Pharma, Inc.
    350,100 USD0SEC
    10,000 shares@ US$35.01Common StockSEC:0001126234-14-000051:1
  • ◇
    VP of Business DevelopmentExecutivesLumos Pharma, Inc.
    58,950 USD0SEC
    5,000 shares@ US$11.79Common StockSEC:0001126234-14-000051:2
  • ▼
    VP of Business DevelopmentExecutivesLumos Pharma, Inc.
    178,200 USD0SEC
    5,000 shares@ US$35.64Common StockSEC:0001126234-14-000051:3
  • ◇
    VP of Business DevelopmentExecutivesLumos Pharma, Inc.
    117,900 USD0SEC
    10,000 shares@ US$11.79Common StockSEC:0001126234-14-000043:0

25 of 29 declarations